Summary:
- This article discusses a new study that has discovered a novel approach to treating cancer using a combination of two existing drugs. The researchers found that a drug that inhibits a protein called CDK7, when combined with a drug that inhibits the PI3K pathway, can effectively kill cancer cells while leaving healthy cells unharmed.
- The study was conducted in mice and human cancer cell lines, and the researchers believe that this combination therapy could be a promising new treatment option for a wide range of cancer types, including breast, lung, and prostate cancer.
- The article highlights the potential of this approach to improve the effectiveness of cancer treatment while reducing the side effects associated with traditional chemotherapy, and suggests that further research is needed to confirm the efficacy and safety of this combination therapy in human clinical trials.